Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome

Cardiovascular Research

Volumn 96, Issue 1, 2012, Pages 90-98

  Chu, Wenfeng ^a   Li, Cui ^a   Qu, Xuefeng ^a   Zhao, Dan ^a   Wang, Xuelian ^a   Yu, Xiangru ^a   Cai, Fulai ^a   Liang, Haihai ^a   Zhang, Yong ^a   Zhao, Xin ^a   Li, Baoxin ^a   Qiao, Guofen ^a   Dong, Deli ^a   Lu, Yanjie ^a   Du, Zhimin ^a   Yang, Baofeng ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Arsenic trioxide; Cardiac fibrosis; HERG channel; Long QT syndrome; TGF 1

Indexed keywords

ARSENIC TRIOXIDE; COLLAGEN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; LY 364947; POTASSIUM CHANNEL HERG; PROTEIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; GUINEA PIG; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84866657641     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs230     Document Type: Article

References (34)

1. Sanz MA, Lo-Coco F. Modern approaches to treating acute promyelocytic leukemia. J Clin Oncol 2011;29:495-503.
2. Unnikrishnan D, Dutcher JP, Varshneya N, Lucariello R, Api M, Garl S et al. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood 2001;97: 1514-1516.
3. Thomas D, Karle CA, Kiehn J. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications. Curr Pharm Des 2006;12:2271-2283.
4. Ficker E, Kuryshev YA, Dennis AT, Obejero-Paz C, Wang L, Hawryluk P et al. Mechanisms of arsenic-induced prolongation of cardiac repolarization. Mol Pharmacol 2004;66:33-44.
5. Sun HL, Chu WF, Dong DL, Liu Y, Bai YL,Wang XH et al. Choline-modulated arsenic trioxide-induced prolongation of cardiac repolarization in Guinea pig. Basic Clin Pharmacol Toxicol 2006;98:381-388.
6. Dennis A, Wang L, Wan X, Ficker E. hERG channel trafficking: novel targets in drug-induced long QT syndrome. Biochem Soc Trans 2007;35:1060-1063.
7. Chen X, Shan H, Zhao J, Hong Y, Bai Y, Sun I et al. L-type calcium current (ICa,L) and inward rectifier potassium current (IK1) are involved in QT prolongation induced by arsenic trioxide in rat. Cell Physiol Biochem 2010;26:967-974.
8. Edge JR. Myocardial fibrosis following arsenical therapy. Lancet 1946;2:675-677.
9. Wu J, Liu J, Waalkes MP, Cheng ML, Li L, Li CX et al. High dietary fat exacerbates arsenic-induced liver fibrosis in mice. Exp Biol Med (Maywood) 2008;233:377-384.
10. Kamkin A, Kiseleva I, Lozinsky I, Scholz H. Electrical interaction of mechanosensitive fibroblasts and myocytes in the heart. Basic Res Cardiol 2005;100:337-345.
11. Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 2011;89:744-753.
12. ChuW, Li X, Li C,Wan L, Shi H, Song X et al. TGFBR3, a potential negative regulator of TGF-b signaling, protects cardiac fibroblasts from hypoxia-induced apoptosis. J Cell Physiol 2011;226:2586-2594.
13. He X, Gao X, Peng L,Wang S, Zhu Y, Ma H et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ Res 2011;108:164-175.
14. Shan H, Zhang Y, Lu Y, Pan Z, Cai B, Wang N et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res 2009;83:465-472.
15. Wang L, Zhu Y, Sharma K. Transforming growth factor-b1 stimulates protein kinase A in mesangial cells. J Biol Chem 1998;273:8522-8527.
16. Roberts AB, Roche NS, Winokur TS, Burmester JK, Sporn MB. Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1. J Clin Invest 1992; 90:2056-2062.
17. Chen J, Sroubek J, Krishnan Y, Li Y, Bian J, McDonald TV. PKA phosphorylation of HERG protein regulates the rate of channel synthesis. Am J Physiol Heart Circ Physiol 2009;296:H1244-H1254.
18. Koumi S, Wasserstrom JA, Ten Eick RE. b-adrenergic and cholinergic modulation of inward rectifier K+ channel function and phosphorylation in guinea-pig ventricle. J Physiol 1995;486:661-678.
19. Karle CA, Zitron E, ZhangW, Kathofer S, SchoelsW, Kiehn J. Rapid component IKr of the guinea-pig cardiac delayed rectifier K+ current is inhibited by b1-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovasc Res 2002;53: 355-362.
20. Siu CW, AuWY, Yung C, Kumana CR, Lau CP, Kwong YL et al. Effects of oral arsenic trioxide therapy on QT intervals in patients with acute promyelocytic leukemia: implications for long-term cardiac safety. Blood 2006;108:103-106.
21. Zhao X, Feng T, Chen H, Shan H, Zhang Y, Lu Y et al. Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: implications in cardiotoxicity. Basic Clin Pharmacol Toxicol 2008;102:419-425.
22. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005;162:1037-1049.
23. Kohl P, Camelliti P, Burton FL, Smith GL. Electrical coupling of fibroblasts and myocytes: relevance for cardiac propagation. J Electrocardiol 2005;38:45-50.
24. Avila G, Medina IM, Jiménez E, Elizondo G, Aguilar CI. Transforming growth factor-b1 decreases cardiac muscle L-type Ca2+ current and charge movement by acting on the Cav1.2 mRNA. Am J Physiol Heart Circ Physiol 2007;292:H622-H631.
25. Ramos-Mondragón R, Vega AV, Avila G. Long-term modulation of Na+ and K+ channels by TGF-b1 in neonatal rat cardiac myocytes. Pflugers Arch 2011;461:235-247.
26. Ramos-Mondragón R, Galindo CA, Avila G. Role of TGF-b on cardiac structural and electrical remodeling. Vasc Health Risk Manag 2008;4:1289-1300.
27. El-Haroun H, Clarke DL, Deacon K, Bradbury D, Clayton A, Sutcliffe A et al. IL-1b, BK, and TGF-b1 attenuate PGI2-mediated cAMP formation in human pulmonary artery smooth muscle cells by multiple mechanisms involving p38 MAP kinase and PKA. Am J Physiol Lung Cell Mol Physiol 2008;294:L553-L562.
28. Vaidyanathan R, Taffet SM, Vikstrom KL, Anumonwo JM. Regulation of cardiac inward rectifier potassium current (IK1) by synapse-associated protein-97. J Biol Chem 2010; 285:28000-28009.
29. Dart C, Leyland ML. Targeting of an A kinase-anchoring protein, AKAP79, to an inwardly rectifying potassium channel, Kir2.1. J Biol Chem 2001;276:20499-20505.
30. Pan X, Dai Y, Li X, Niu N, LiW, Liu F et al. Inhibition of arsenic-induced rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-b/Smad activation. Toxicol Appl Pharmacol 2011;254:323-331.
31. Oka M, Iwata C, Suzuki HI, Kiyono K, Morishita Y, Watabe T et al. Inhibition of endogenous TGF-b signaling enhances lymphangiogenesis. Blood 2008;111: 4571-4579.
32. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB et al. Arsenic trioxide controls the fate of the PML-RARa oncoprotein by directly binding PML. Science 2010; 328:240-243.
33. Lin HK, Bergmann S, Pandolfi PP. Cytoplasmic PML function in TGF-b signalling. Nature 2004;431:205-211.
34. Raghu KG, Yadav GK, Singh R, Prathapan A, Sharma S, Bhadauria S. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J Environ Pathol Toxicol Oncol 2009;28:241-252.